Showing results (401-410 of 563) with videos related to

Sort By:
Pageof 57
Frontiers in Molecular Biosciences|May 14, 2021
Serum Cytokine Profiling Identifies Axl as a New Biomarker Candidate for Active Eosinophilic Granulomatosis With PolyangiitisJianjuan Ma, Cong Dong, Shushan Wei, et al.
Plos One|March 15, 2023
Association of lymphopenia and RDW elevation with risk of mortality in acute aortic dissectionDan Yu, Peng Chen, Xueyan Zhang, et al.
International Journal of Pharmaceutics|August 6, 2021
Folate receptor-targeting semiconducting polymer dots hybrid mesoporous silica nanoparticles against rheumatoid arthritis through synergistic photothermal therapy, photodynamic therapy, and chemotherapyXiangyu Li, Shixin Zhang, Xueyan Zhang, et al.
Scientific Reports|January 2, 2025
Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male miceMin Liu, Zongzhuang Wen, Dapeng Zhao, et al.
ACS Applied Materials & Interfaces|April 1, 2024
Changing Cinnamaldehyde Skeleton Achieves Antibacterial NanoswitchXiaoying Zhao, Ruoyan Miao, Tianze Xu, et al.
Frontiers in Immunology|January 23, 2024
HOXA3 functions as the on-off switch to regulate the development of hESC-derived third pharyngeal pouch endoderm through EPHB2-mediated Wnt pathwayYingjie Fu, Xueyan Zhang, Haibin Wu, et al.
Digestive Diseases and Sciences|December 7, 2014
Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell CarcinomaRen Zhang, Xiaonan Chen, Shengjie Zhang, et al.
Targeted Oncology|July 5, 2019
Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung AdenocarcinomaChanghui Li, Bo Zhang, Jindong Guo, et al.
Journal of Biomedical Nanotechnology|June 27, 2018
Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene TherapyRui Zhang, Ke Men, Xueyan Zhang, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2016
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in ChinaJianlin Xu, Yanwei Zhang, Bo Jin, et al.
Pageof 57